Literature DB >> 7806380

Immunoreactivity and bioactivity of lipopolysaccharide-binding protein in normal and heat-inactivated sera.

K Mészáros1, S Aberle, M White, J B Parent.   

Abstract

The lipopolysaccharide (LPS)-potentiating effect of serum is due to LPS-binding protein (LBP), which facilitates the binding of LPS to CD14 receptors. We observed a remarkable heat sensitivity of recombinant LBP and various sera with respect to both immunoreactivity (measured by enzyme-linked immunosorbent assay) and bioactivity (potentiation of LPS induction of tumor necrosis factor in monocytes). Human sera were more active and more heat sensitive than fetal bovine sera. The commonly practiced heat inactivation of human serum (56 degrees C, 30 min) resulted in a 70% loss of bioactivity, which caused an apparent decrease in the potency of LPS.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7806380      PMCID: PMC173003          DOI: 10.1128/iai.63.1.363-365.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Structure and function of lipopolysaccharide binding protein.

Authors:  R R Schumann; S R Leong; G W Flaggs; P W Gray; S D Wright; J C Mathison; P S Tobias; R J Ulevitch
Journal:  Science       Date:  1990-09-21       Impact factor: 47.728

2.  Control of lipopolysaccharide-high density lipoprotein binding by acute phase protein(s).

Authors:  P S Tobias; R J Ulevitch
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

3.  Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein.

Authors:  P S Tobias; K Soldau; R J Ulevitch
Journal:  J Biol Chem       Date:  1989-06-25       Impact factor: 5.157

Review 4.  A new model of macrophage stimulation by bacterial lipopolysaccharide.

Authors:  R J Ulevitch; J C Mathison; R R Schumann; P S Tobias
Journal:  J Trauma       Date:  1990-12

5.  CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein.

Authors:  S D Wright; R A Ramos; P S Tobias; R J Ulevitch; J C Mathison
Journal:  Science       Date:  1990-09-21       Impact factor: 47.728

6.  Plasma lipopolysaccharide (LPS)-binding protein. A key component in macrophage recognition of gram-negative LPS.

Authors:  J C Mathison; P S Tobias; E Wolfson; R J Ulevitch
Journal:  J Immunol       Date:  1992-07-01       Impact factor: 5.422

Review 7.  Participation of lipopolysaccharide-binding protein in lipopolysaccharide-dependent macrophage activation.

Authors:  P S Tobias; J Mathison; D Mintz; J D Lee; V Kravchenko; K Kato; J Pugin; R J Ulevitch
Journal:  Am J Respir Cell Mol Biol       Date:  1992-09       Impact factor: 6.914

8.  Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes.

Authors:  D Heumann; P Gallay; C Barras; P Zaech; R J Ulevitch; P S Tobias; M P Glauser; J D Baumgartner
Journal:  J Immunol       Date:  1992-06-01       Impact factor: 5.422

9.  Endotoxemia in human septic shock.

Authors:  R L Danner; R J Elin; J M Hosseini; R A Wesley; J M Reilly; J E Parillo
Journal:  Chest       Date:  1991-01       Impact factor: 9.410

Review 10.  Endotoxaemia: an early predictor of septicaemia in febrile patients.

Authors:  S J van Deventer; H R Buller; J W ten Cate; A Sturk; W Pauw
Journal:  Lancet       Date:  1988-03-19       Impact factor: 79.321

View more
  10 in total

1.  Increased circulating levels of lipopolysaccharide binding protein in children with Escherichia coli O157:H7 hemorrhagic colitis and hemolytic uremic syndrome.

Authors:  F Proulx; E Seidman; M M Mariscalco; K Lee; S Caroll
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

2.  Lipopolysaccharide binding protein is down-regulated during acute liver failure.

Authors:  Grace L Su; Robert J Fontana; Kartik Jinjuvadia; Jill Bayliss; Stewart C Wang
Journal:  Dig Dis Sci       Date:  2012-01-26       Impact factor: 3.199

3.  Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia.

Authors:  D Pajkrt; J E Doran; F Koster; P G Lerch; B Arnet; T van der Poll; J W ten Cate; S J van Deventer
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

4.  Examination of early interactions between Haemophilus ducreyi and host cells by using cocultured HaCaT keratinocytes and foreskin fibroblasts.

Authors:  F R Zaretzky; T H Kawula
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

5.  Yersinia pestis targets neutrophils via complement receptor 3.

Authors:  Peter M Merritt; Thomas Nero; Lesley Bohman; Suleyman Felek; Eric S Krukonis; Melanie M Marketon
Journal:  Cell Microbiol       Date:  2014-11-25       Impact factor: 3.715

6.  Involvement of CD14 and beta2-integrins in activating cells with soluble and particulate lipopolysaccharides and mannuronic acid polymers.

Authors:  T H Flo; L Ryan; L Kilaas; G Skjâk-Braek; R R Ingalls; A Sundan; D T Golenbock; T Espevik
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

7.  Endotoxin, cytokines, and endotoxin binding proteins in obstructive jaundice and after preoperative biliary drainage.

Authors:  A N Kimmings; S J van Deventer; H Obertop; E A Rauws; K Huibregtse; D J Gouma
Journal:  Gut       Date:  2000-05       Impact factor: 23.059

8.  Peroxide-mediated chromatin remodelling of a nuclear factor kappa B site in the mouse inducible nitric oxide synthase promoter.

Authors:  Junping Wei; Hongtao Guo; Chengjiang Gao; Paul C Kuo
Journal:  Biochem J       Date:  2004-02-01       Impact factor: 3.857

9.  Selectivity analysis of single binder assays used in plasma protein profiling.

Authors:  Maja Neiman; Claudia Fredolini; Henrik Johansson; Janne Lehtiö; Per-Åke Nygren; Mathias Uhlén; Peter Nilsson; Jochen M Schwenk
Journal:  Proteomics       Date:  2013-11-18       Impact factor: 3.984

10.  Prognostic Value and Daily Trend of Interleukin-6, Neutrophil CD64 Expression, C-Reactive Protein and Lipopolysaccharide-Binding Protein in Critically Ill Patients: Reliable Predictors of Outcome or Not?

Authors:  Dragan Djordjevic; Janko Pejovic; Maja Surbatovic; Jasna Jevdjic; Sonja Radakovic; Milic Veljovic; Aneta Peric; Tamara Andjelic; Nada Popovic
Journal:  J Med Biochem       Date:  2015-09-19       Impact factor: 3.402

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.